Senior Director of Drug Development
Jerry Meng has over 20 years dedicated to pharmaceutical research and development from bench to clinic to commercial and has 22 international patents and patent applications published 9 international journals publications. During his tenure at Pfizer, he joined teams at R&D division with six different projects to discover several clinical drug candidates. For one of successful oncology projects, he was recognized as Winner of the 38th Annual National Inventor of the Year Award for the invention of Pfizer’s Xalkori® (Crizotinib) for the treatment of lung cancer, the first new drug approved for non-small cell lung cancer in the U.S. under FDA’s accelerated approval program.
As COO at Jenovo PharmTech, he built and led project teams successfully to carry out several generic medicine projects with different Chinese pharmaceutical companies and cooperate with business partners in China to transfer manufacture technology of generic medicine. Identify potential outsourced manufacturing companies (CMOs) for US pharmaceutical companies in China and provide the required technology and quality management. Engaged in the research and development of new targeted anti-tumor drugs and new dosage forms of drugs, as well as the development of US generic drugs in the Chinese market.